HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-NOV-11 3UGC
TITLE STRUCTURAL BASIS OF JAK2 INHIBITION BY THE TYPE II INHIBTOR NVP-BBT594
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: UNP RESIDUES 840-1132;
COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2;
COMPND 6 EC: 2.7.10.2;
COMPND 7 ENGINEERED: YES;
COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108;
SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF9DE;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PACG2TTEV
KEYWDS SMALL MOLECULE INHIBITOR, ATP BINDING, TRANSFERASE-TRANSFERASE
KEYWDS 2 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR C.SCHEUFLER,G.A.TAVARES,P.W.MANLEY,C.PISSOT-SOLDERMANN,M.KROEMER
REVDAT 5 13-SEP-23 3UGC 1 REMARK SEQADV
REVDAT 4 11-APR-18 3UGC 1 COMPND
REVDAT 3 29-AUG-12 3UGC 1 JRNL
REVDAT 2 04-JUL-12 3UGC 1 HETNAM
REVDAT 1 16-MAY-12 3UGC 0
JRNL AUTH R.ANDRAOS,Z.QIAN,D.BONENFANT,J.RUBERT,E.VANGREVELINGHE,
JRNL AUTH 2 C.SCHEUFLER,F.MARQUE,C.H.REGNIER,A.DE POVER,H.RYCKELYNCK,
JRNL AUTH 3 N.BHAGWAT,P.KOPPIKAR,A.GOEL,L.WYDER,G.TAVARES,F.BAFFERT,
JRNL AUTH 4 C.PISSOT-SOLDERMANN,P.W.MANLEY,C.GAUL,H.VOSHOL,R.L.LEVINE,
JRNL AUTH 5 W.R.SELLERS,F.HOFMANN,T.RADIMERSKI
JRNL TITL MODULATION OF ACTIVATION-LOOP PHOSPHORYLATION BY JAK
JRNL TITL 2 INHIBITORS IS BINDING MODE DEPENDENT.
JRNL REF CANCER DISCOV V. 2 512 2012
JRNL REFN ISSN 2159-8274
JRNL PMID 22684457
JRNL DOI 10.1158/2159-8290.CD-11-0324
REMARK 2
REMARK 2 RESOLUTION. 1.34 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.9.6
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.34
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.83
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2
REMARK 3 NUMBER OF REFLECTIONS : 79050
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.177
REMARK 3 R VALUE (WORKING SET) : 0.176
REMARK 3 FREE R VALUE : 0.189
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 3953
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.34
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.38
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.15
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 5733
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2211
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5446
REMARK 3 BIN R VALUE (WORKING SET) : 0.2211
REMARK 3 BIN FREE R VALUE : 0.2213
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.01
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 287
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2239
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 48
REMARK 3 SOLVENT ATOMS : 275
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 18.80
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.98
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.51790
REMARK 3 B22 (A**2) : -0.32350
REMARK 3 B33 (A**2) : 0.84140
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -1.11300
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.141
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.047
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 2404 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 3240 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 886 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 67 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 339 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 2404 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 287 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 3061 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.09
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.94
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 65.60
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 3UGC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-11.
REMARK 100 THE DEPOSITION ID IS D_1000068719.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 30-JUL-09
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X10SA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9999
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 79053
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.340
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1
REMARK 200 DATA REDUNDANCY : 3.400
REMARK 200 R MERGE (I) : 0.04200
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.4000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.34
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.37
REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0
REMARK 200 DATA REDUNDANCY IN SHELL : 3.40
REMARK 200 R MERGE FOR SHELL (I) : 0.42900
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.300
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: PDB ENTRY 2B7A
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 54.39
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.8M SODIUM MALONATE PH 6.0, 0.1M
REMARK 280 GLYCINE-PH 8.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298.0K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.48500
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.69500
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.48500
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.69500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 838
REMARK 465 SER A 839
REMARK 465 ASP A 840
REMARK 465 PRO A 841
REMARK 465 THR A 842
REMARK 465 VAL A 1000
REMARK 465 LEU A 1001
REMARK 465 PRO A 1002
REMARK 465 GLN A 1003
REMARK 465 ASP A 1004
REMARK 465 LYS A 1005
REMARK 465 GLU A 1006
REMARK 465 PHE A 1007
REMARK 465 PHE A 1008
REMARK 465 LYS A 1009
REMARK 465 VAL A 1010
REMARK 465 LYS A 1011
REMARK 465 GLU A 1012
REMARK 465 MET A 1130
REMARK 465 ALA A 1131
REMARK 465 GLY A 1132
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 857 CG CD CE NZ
REMARK 470 GLN A 872 CG CD OE1 NE2
REMARK 470 GLU A 890 CD OE1 OE2
REMARK 470 GLN A 942 CD OE1 NE2
REMARK 470 THR A 998 OG1 CG2
REMARK 470 GLU A1015 CG CD OE1 OE2
REMARK 470 GLU A1097 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 869 70.65 -116.85
REMARK 500 GLN A 872 25.05 47.99
REMARK 500 THR A 875 -159.90 -129.26
REMARK 500 ARG A 975 -37.27 83.55
REMARK 500 ASP A 994 97.88 -162.81
REMARK 500 THR A 998 64.52 -113.44
REMARK 500 TYR A1050 -33.90 -31.16
REMARK 500 SER A1054 0.87 84.46
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 046 A 1201
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MLI A 1202
DBREF 3UGC A 840 1132 UNP O60674 JAK2_HUMAN 840 1132
SEQADV 3UGC GLY A 838 UNP O60674 EXPRESSION TAG
SEQADV 3UGC SER A 839 UNP O60674 EXPRESSION TAG
SEQADV 3UGC PHE A 1007 UNP O60674 TYR 1007 ENGINEERED MUTATION
SEQADV 3UGC PHE A 1008 UNP O60674 TYR 1008 ENGINEERED MUTATION
SEQRES 1 A 295 GLY SER ASP PRO THR GLN PHE GLU GLU ARG HIS LEU LYS
SEQRES 2 A 295 PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER VAL
SEQRES 3 A 295 GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR GLY
SEQRES 4 A 295 GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR GLU
SEQRES 5 A 295 GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE LEU
SEQRES 6 A 295 LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS GLY
SEQRES 7 A 295 VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU ILE
SEQRES 8 A 295 MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR LEU
SEQRES 9 A 295 GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU LEU
SEQRES 10 A 295 GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR LEU
SEQRES 11 A 295 GLY THR LYS ARG TYR ILE HIS ARG ASP LEU ALA THR ARG
SEQRES 12 A 295 ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE GLY
SEQRES 13 A 295 ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS GLU
SEQRES 14 A 295 PHE PHE LYS VAL LYS GLU PRO GLY GLU SER PRO ILE PHE
SEQRES 15 A 295 TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SER
SEQRES 16 A 295 VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR
SEQRES 17 A 295 GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO PRO
SEQRES 18 A 295 ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN GLY
SEQRES 19 A 295 GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS ASN
SEQRES 20 A 295 ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP GLU
SEQRES 21 A 295 ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN VAL
SEQRES 22 A 295 ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG VAL
SEQRES 23 A 295 ASP GLN ILE ARG ASP ASN MET ALA GLY
HET 046 A1201 41
HET MLI A1202 7
HETNAM 046 5-{[6-(ACETYLAMINO)PYRIMIDIN-4-YL]OXY}-N-{4-[(4-
HETNAM 2 046 METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)
HETNAM 3 046 PHENYL}-2,3-DIHYDRO-1H-INDOLE-1-CARBOXAMIDE
HETNAM MLI MALONATE ION
FORMUL 2 046 C28 H30 F3 N7 O3
FORMUL 3 MLI C3 H2 O4 2-
FORMUL 4 HOH *275(H2 O)
HELIX 1 1 GLU A 845 ARG A 847 5 3
HELIX 2 2 THR A 888 SER A 904 1 17
HELIX 3 3 TYR A 918 ARG A 923 1 6
HELIX 4 4 SER A 936 HIS A 944 1 9
HELIX 5 5 LYS A 945 ILE A 948 5 4
HELIX 6 6 ASP A 949 LYS A 970 1 22
HELIX 7 7 ALA A 978 ARG A 980 5 3
HELIX 8 8 SER A 1016 TYR A 1021 5 6
HELIX 9 9 ALA A 1022 SER A 1029 1 8
HELIX 10 10 SER A 1032 TYR A 1050 1 19
HELIX 11 11 SER A 1056 GLY A 1066 1 11
HELIX 12 12 GLY A 1071 ASN A 1084 1 14
HELIX 13 13 PRO A 1095 TRP A 1106 1 12
HELIX 14 14 ASN A 1109 ARG A 1113 5 5
HELIX 15 15 SER A 1115 ASN A 1129 1 15
SHEET 1 A 5 LEU A 849 LYS A 857 0
SHEET 2 A 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853
SHEET 3 A 5 GLU A 877 LEU A 884 -1 O GLU A 877 N TYR A 868
SHEET 4 A 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880
SHEET 5 A 5 TYR A 913 CYS A 917 -1 N GLY A 915 O ILE A 928
SHEET 1 B 2 ILE A 982 ASN A 986 0
SHEET 2 B 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983
SITE 1 AC1 24 LEU A 855 VAL A 863 ALA A 880 GLU A 898
SITE 2 AC1 24 LEU A 902 LEU A 905 ILE A 910 VAL A 911
SITE 3 AC1 24 LEU A 927 MET A 929 GLU A 930 TYR A 931
SITE 4 AC1 24 LEU A 932 GLY A 935 LEU A 967 ILE A 973
SITE 5 AC1 24 HIS A 974 LEU A 983 ILE A 992 GLY A 993
SITE 6 AC1 24 ASP A 994 PHE A 995 HOH A1319 HOH A1370
SITE 1 AC2 9 SER A1115 ARG A1117 HOH A1383 HOH A1384
SITE 2 AC2 9 HOH A1385 HOH A1414 HOH A1441 HOH A1503
SITE 3 AC2 9 HOH A1566
CRYST1 106.970 69.390 50.800 90.00 98.98 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009348 0.000000 0.001477 0.00000
SCALE2 0.000000 0.014411 0.000000 0.00000
SCALE3 0.000000 0.000000 0.019929 0.00000